248 lines
No EOL
11 KiB
HTML
248 lines
No EOL
11 KiB
HTML
<!-- Changed ON 09/24/2024 -->
|
|
<!-- Google Tag Manager -->
|
|
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
|
|
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
|
|
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
|
|
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
|
|
})(window,document,'script','dataLayer','GTM-T2DH393N');</script>
|
|
<!-- End Google Tag Manager -->
|
|
|
|
|
|
|
|
|
|
|
|
<HTML lang="en-US">
|
|
|
|
<!-- From NoticeTemplate.txt -->
|
|
|
|
|
|
|
|
|
|
<HEAD>
|
|
|
|
|
|
<TITLE>NOT-OD-12-146: NIH Offers Niche Assessment Program to SBIR and STTR Phase I Awardees
|
|
|
|
</TITLE>
|
|
|
|
|
|
<META NAME="description" CONTENT="NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NIH Offers Niche Assessment Program to SBIR and STTR Phase I Awardees
|
|
|
|
NOT-OD-12-146. NIH">
|
|
<META NAME="Keywords" CONTENT="NOT-OD-12-146: NIH Offers Niche Assessment Program to SBIR and STTR Phase I Awardees
|
|
|
|
">
|
|
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
|
<link href="../guide_styles/css/bootstrap.min.css" rel="stylesheet" media="screen">
|
|
<link href="../guide_styles/css/style.css" rel="stylesheet" media="screen">
|
|
<link href="../guide_styles/css/FOAM_Style.css" rel="stylesheet">
|
|
|
|
|
|
|
|
</HEAD>
|
|
|
|
<BODY>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<div class="container">
|
|
<div class="row">
|
|
<div class="col-xs-12">
|
|
|
|
|
|
|
|
<div class=WordSection1>
|
|
<p class=MsoTitle><a name="_Toc258852634">NIH Offers Niche
|
|
Assessment Program to SBIR and STTR Phase I Awardees</a></p>
|
|
<div class=regulartext align=center>
|
|
<hr size=2 width="100%" noshade align=center>
|
|
</div>
|
|
<span class="heading3">Notice Number:</span><span class="addtitle"> NOT-OD-12-146 </span> <br>
|
|
<br>
|
|
<div class="heading3">Key Dates</div>
|
|
<p class=regulartext><strong>Release
|
|
Date:</strong> August 31, 2012 </p>
|
|
<div class="heading3">Issued by</div>
|
|
<p class=regulartext>National Institutes of Health (<a href="http://www.nih.gov">NIH</a>)</p>
|
|
<div class="heading2">Purpose</div>
|
|
<p class=regulartext>NIH announces the availability of a Niche Assessment Program
|
|
for its SBIR/STTR Phase I awardees funded in fiscal years (FY) 2012 and 2013.
|
|
All active NIH SBIR/STTR Phase I awardees (by grant or contract) as well as
|
|
those small businesses selected to receive a Phase I award in the first three
|
|
months of the upcoming fiscal year will be eligible to participate. This
|
|
program can help jump-start a company’s commercialization efforts by
|
|
providing the market insight and data that can be used to strategically
|
|
position its technology in the marketplace, by assisting companies with their
|
|
development of commercialization plans for Phase II applications, and by
|
|
introducing small businesses to potential partners.</p>
|
|
<p class=regulartext>A third party, unbiased assessment of appropriate market
|
|
niches for products/services that are being developed by NIH’s SBIR/STTR Phase
|
|
I awardees will be performed by Foresight Science & Technology. Using its
|
|
Technology Niche Analysis (TNA ), Foresight will perform the due diligence on
|
|
markets appropriate for each SBIR technology and develop an in-depth report for
|
|
each SBIR/STTR awardee that addresses: </p>
|
|
<ul>
|
|
<li>needs and
|
|
concerns of end-users </li>
|
|
<li>competing
|
|
technologies and competing products </li>
|
|
<li>competitive
|
|
advantage of the SBIR/STTR-developed technology </li>
|
|
<li>market
|
|
size and potential market share (may include national and/or global markets) </li>
|
|
<li>barriers
|
|
to market entry (may include, but is not limited to pricing, competition,
|
|
government regulations, manufacturing challenges, capital requirements, etc.) </li>
|
|
<li>market
|
|
drivers </li>
|
|
<li>status of
|
|
market and industry trends </li>
|
|
<li>potential
|
|
customers, licensees, investors, or other commercialization partners </li>
|
|
<li>price
|
|
customers are likely to pay </li>
|
|
</ul>
|
|
<p class=regulartext>The analysis has three steps: <br>
|
|
<br>
|
|
(1) In the first step, Foresight will gather the pertinent information needed
|
|
from the SBIR/STTR awardee to identify feasible applications of the technology.
|
|
Often times, several non-obvious uses are found, and such secondary
|
|
applications may provide a path to market that is faster than the primary
|
|
biomedical use. <br>
|
|
<br>
|
|
(2) In the second step, Foresight will analyze the selected use of the
|
|
technology to determine the end-user needs, current and emerging competing
|
|
technologies, market dynamics, socio-economic trends and market drivers, and to
|
|
quantify the market size and participant's possible share. This second step
|
|
determines the technology's current competitive advantages and how to improve
|
|
competitiveness. <br>
|
|
<br>
|
|
(3) In the third step, Foresight will recommend a market entry strategy. This
|
|
strategy includes how to market the technology to end-users, how to obtain
|
|
outside partners, and also projects revenues for the technology. Likely lead
|
|
customers, testing centers, suppliers, manufacturers, and/or other relevant
|
|
organizations interested in participating in the downstream research as beta
|
|
testers or concurrent engineering advisors will be identified. <br>
|
|
<br>
|
|
To validate the analyses and recommendations, Foresight will identify and
|
|
qualify companies or funding agencies that might be interested in becoming
|
|
commercialization partners. Follow-up communication with these potential
|
|
partners will be the responsibility of the small business. <br>
|
|
<br>
|
|
The Niche Assessment Program is appropriate for all types of technologies,
|
|
e.g., those developing clinical products such as devices, drugs, biologics, and
|
|
therapeutics, as well as those developing software, educational, and
|
|
multi-media behavioral science products. The program is also appropriate for
|
|
those seeking strategic alliances, investors, and/or immediate customers. <br>
|
|
<br>
|
|
One hundred twenty five (125) slots are available and will be filled on a
|
|
first come, first served basis. For those with multiple awards, only one
|
|
project per company will be accepted for the program. The average time to complete
|
|
a Technology Niche Analysis is 2 to 3 months.
|
|
Since reports will be generated in the order the applications were received,
|
|
all 125 reports will be completed between November 2012 and early March 2013.
|
|
However, awardees may indicate a preference when they would like to receive the
|
|
TNA report in the registration forms
|
|
below. NIH and Foresight will try to accommodate such preferences if
|
|
possible. The Technology Niche Analysis
|
|
report may be helpful in the preparation of the commercialization plan that is
|
|
required in a SBIR/STTR Phase II application and, as such, applicants should
|
|
consider the timing of their Phase II submission. The amount of time a program
|
|
participant will need to expend is minimal (perhaps only a few hours) and
|
|
participation is free.</p>
|
|
<p class=regulartext>To participate in the program, complete the on-line registration
|
|
form available at: <a href="http://2012nihsetupform.foresightst.com" Title="Link to Non-U.S. Government Site">http://2012nihsetupform.foresightst.com</a></p>
|
|
<p class=regulartext>For assistance with submitting the on-line Set-Up Form
|
|
please contact:</p>
|
|
<p class=regulartext> Mr. Ryan Hill, MBA<br>
|
|
Controller, Finance & Administration<br>
|
|
Foresight Science & Technology<br>
|
|
Telephone: (401) 273-4844, ext. 10<br>
|
|
Fax: (401) 273-4744<br>
|
|
Email: <a href="/cdn-cgi/l/email-protection#a1d3d8c0cf8fc9c8cdcde1c7ced3c4d2c8c6c9d5d2d58fc2cecc"><span class="__cf_email__" data-cfemail="fc8e859d92d294959090bc9a938e998f959b94888f88d29f9391">[email protected]</span></a></p>
|
|
<div class="heading2">Inquiries</div>
|
|
<p class=regulartext>Specific questions about TNA's may be directed to: <br>
|
|
</p>
|
|
<p class=regulartext>Konstantin Izvolsky, PhD.<br>
|
|
Director, Assessments<br>
|
|
Foresight Science & Technology<br>
|
|
Telephone: (401) 273-4844, ext. 25<br>
|
|
Fax: (401) 273-4744<br>
|
|
Email: <a href="/cdn-cgi/l/email-protection#016a6e6f7275606f75686f2f687b776e6d726a7841676e7364726866697572752f626e6c"><span class="__cf_email__" data-cfemail="9cf7f3f2efe8fdf2e8f5f2b2f5e6eaf3f0eff7e5dcfaf3eef9eff5fbf4e8efe8b2fff3f1">[email protected]</span></a></p>
|
|
<p class=regulartext>General questions about Niche Assessment Program may be
|
|
directed to:</p>
|
|
<p class=regulartext> Robert Vinson <br>
|
|
Assistant Program Manager<br>
|
|
NIH SBIR/STTR Program <br>
|
|
Office of Extramural Programs <br>
|
|
National Institutes of Health <br>
|
|
Telephone: (301) 435-2713 <br>
|
|
Fax: (301) 480-0146 <br>
|
|
Email: <a href="/cdn-cgi/l/email-protection#ed9e8f849fad8289c3838485c38a829b"><span class="__cf_email__" data-cfemail="fa89989388ba959ed4949392d49d958c">[email protected]</span></a> </p>
|
|
</div>
|
|
|
|
|
|
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="col-xs-12">
|
|
<P>
|
|
<HR>
|
|
<A HREF="/grants/guide/WeeklyIndex.cfm?08-31-12">Weekly TOC for this Announcement</A><br>
|
|
<A HREF="/grants/guide/index.html">NIH Funding Opportunities and Notices</A>
|
|
<hr>
|
|
</div>
|
|
</div>
|
|
<link rel="stylesheet" type="text/css" media="print" href="css/notices_print.css " />
|
|
|
|
|
|
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
|
|
<div class="col-sm-4"> <a href="/grants/oer.htm"><img src="/images7/nih-oer-logo.jpg" alt="NIH Office of Extramural Research Logo" usemap="#Map2" border="0"></a>
|
|
<map name="Map2" id="Map2">
|
|
<area shape="rect" coords="89,17,359,39" href="http://www.nih.gov" />
|
|
<area shape="rect" coords="91,39,286,58" href="http://grants.nih.gov/grants/oer.htm" />
|
|
<area shape="rect" coords="3,5,78,55" href="http://grants.nih.gov/grants/oer.htm" />
|
|
</map>
|
|
</div>
|
|
<div class="col-sm-4">
|
|
<div style="float:left; padding: 5 5 5 70"> <a href="https://www.hhs.gov/"><img src="/images7/dhhs_sm.gif" width="36" height="37" border="0" alt="Department of Health and Human Services (HHS) - Home Page" long desc="Logo, circular in shape, depicting an American eagle in-flight with stylized profiles of human faces appearing on the trailing edge of the wings. The perimeter of the logo is encircled with the words 'Department of Health and Human Services U S A'"></a></div>
|
|
<div style="padding: 5 5 5 5;">Department of Health<br>
|
|
and Human Services (HHS)</div>
|
|
</div>
|
|
<div class="col-sm-4">
|
|
<div style="padding: 5 5 5 0" align="center"> <a href="https://www.usa.gov/"><img src="/images7/USA_Gov_logo.gif" border="0" alt="USA.gov - Government Made Easy" long desc="Logo,- the words 'USA.gov - Government Made Easy' with single streaking star above the logo"></a> </div>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
<div class="col-xs-12" align="center" style="padding: 20 5 5 5"> <span style="color:#6E6E6E; font-size:1.0em; font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif">NIH... Turning Discovery Into Health<sup>®</sup></span> </div>
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
<div class="col-xs-12" align="center">
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
</div>
|
|
|
|
<script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></BODY>
|
|
</HTML> |